Novartis | NVS - Assets

Stock Price
145.47
Daily Change
-2.06 -1.40%
Monthly
-3.46%
Yearly
29.62%
Q2 Forecast
142.62

Novartis reported $110.95B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bausch Health Companies USD 26.37B 458M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Canopy Growth CAD 1.11B 36.35M Dec/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Glaxosmithkline GBP 82.34B 102.25M Dec/2025
J&J USD 200.89B 1.68B Mar/2026
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 110.95B 3.66B Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Pacira USD 1.26B 32.66M Dec/2025
Perrigo USD 8.54B 1.55B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Phibro Animal Health USD 1.41B 20.03M Dec/2025
Prestige Brands USD 3.49B 52.46M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Sanofi EUR 126.81B 25.48B Dec/2025
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025
Zoetis USD 15.47B 308M Dec/2025